段立军,孙博航
DUAN Li-jun,SUN Bo-hang(School of Traditional Chinese Materia Medica

• 1:沈阳药科大学中药学院

摘要(Abstract)：

目的对黄芪甲苷的研究概况进行综述,为黄芪甲苷的深入研究提供依据。方法通过阅读近5年来70余篇相关文献报道,从黄芪甲苷的药理活性、理化性质、含量测定方法、药动学和组织分布以及提取精制工艺等方面对其目前的研究概况进行综述。结果黄芪甲苷具有免疫调节、器官保护、降糖、调节细胞凋亡、抗炎、抗病毒及生殖毒性等多方面的药理作用。结论为黄芪甲苷药用的开发提供参考依据。
Objective To review the researches on the astragaloside Ⅳ,one of the main active constituents of Astragalus membranaceus(Fisch.)Bge.var.mongholicus(Bge.)Hsiao or A.membranaceus(Fisch.)Bge.,and provide the basis for its further research.Methods Papers published mainly in the recent 5 years had been reviewed including the pharmacological activity,physical and chemical property,content determination,pharmacokinetics and purification,etc.Results The astragaloside Ⅳ was reported to have the immune regulation,organs protection,hypoglycemic,apoptosis regulation,anti-inflammatory and anti-virus effects.The reproductive toxicity effect of astragaloside Ⅳ was reviewed for the first time.Conclusions This review provides a useful reference for the pharmaceutical application of astragaloside Ⅳ.

关键词(KeyWords)： 黄芪甲苷;药理活性;提取工艺;含量测定;毒性
astragaloside Ⅳ;pharmacological activity;extraction technology;content determination;toxicity

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 段立军,孙博航
DUAN Li-jun,SUN Bo-hang(School of Traditional Chinese Materia Medica

DOI: 10.14066/j.cnki.cn21-1349/r.2011.05.011

参考文献(References)：

• [1]国家药典委员会.中华人民共和国药典:一部[M].北京:中国医药科技出版社,2010:283-284.
• [2]南京中医药大学.中药大辞典[M].2版.上海:上海科学技术出版社,2006:2809-2815.
• [3]张峰,高鹏,彭俊华.黄芪多糖及黄芪甲苷对巨噬细胞吞噬结核杆菌作用的研究[J].西北国防医学杂志,2005,26(6):434-436.
• [4]樊懿,吴大正,胡之璧.黄芪甲甙对组胺引起的血管内皮细胞单层通透性增高的作用[J].中国中医基础医学杂志,2001,7(2):36-38.
• [5]曲友直,赵燕玲,李敏,等.黄芪甲苷对脑缺血再灌注后血脑屏障的保护作用及occludin蛋白表达的影响[J].卒中与神经疾病,2010,17(2):92-93.
• [6]周军,刘军.黄芪甲甙对大鼠局灶性脑缺血的保护作用及机制研究[J].医学临床研究,2008,25(5):814-816.
• [7]于芹超,朱同玉,张永康,等.黄芪甲甙对缺血再灌注损伤肾脏远期MCP-1表达的作用[J].复旦学报:医学版,2004,31(6):588-591.
• [8]于芹超,朱同玉,张永康.黄芪甲甙对大鼠肾缺血再灌注损伤的远期防护作用[J].中华医学杂志,2004,84(17):1412-1415.
• [9]于芹超,朱同玉,张永康.黄芪甲甙对大鼠肾缺血再灌注损伤的保护作用[J].中华实验外科杂志,2004,21(3):379.
• [10]廖秀清,熊平,肖晓山.黄芪甲甙对大鼠肺缺血再灌注损伤的保护作用[J].广东医学,2009,30(12):1778-1780.
• [11]于小华,张平,李健芝.黄芪甲甙对肺缺血-再灌注损伤大鼠的保护作用[J].现代中西医结合杂志,2008,17(33):5122-5123.
• [12]DU Qiang,CHEN Zhen,ZHOU Lin-fu,et al.Inhibitoryeffects of astragaloside IV on ovalbumin-induced chron-ic experimental asthma[J].Can J Physiol Pharmacol,2008,86(7):449-457.
• [13]胡炯宇,黄跃生,宋华培,等.槲皮素和黄芪甲苷对大鼠缺氧心肌细胞的保护作用[J].中华烧伤杂志,2007,23(3):175-178.
• [14]汪明辉,李双杰.黄芪甲苷抗氧化机制对病毒性心肌炎保护作用的研究[J].临床儿科杂志,2007,25(10):825-827.
• [15]许晓乐,季晖,谷舒怡,等.黄芪甲苷对异丙肾上腺素所致小鼠心肌肥厚的保护作用[J].中国药科大学学报,2007,38(5):451-455.
• [16]LIU Hao,WEI Wei,SUN Wu-yi,et al.Protectiveeffects of astragaloside IV on porcine-serum-inducedhepatic fibrosis in rats andin vitroeffects on hepaticstellate cells[J].J Ethnopharmacol,2009,122(3):502-508.
• [17]CHAN Wang-sai,DURAIRAJAN S S,LU Jia-hong,etal.Neuroprotective effects of astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture[J].Neurochem Int,2009,55(6):414-422.
• [18]ZHU Shao-qing,QI Lei,RUI Yan-fang,et al.Astra-galoside IV inhibits spontaneous synaptic transmis-sion and synchronized Ca2+oscillations on hippocam-pal neurons.[J].Acta Pharmacol Sin,2008,29(1):57-64.
• [19]LV Lin,WU Shao-yu,WANG Guang-fa,et al.Effect ofastragaloside IV on hepatic glucose-regulating enzymesin diabetic mice induced by a high-fat diet and strepto-zotocin.[J].Phytother Res,2010,24(2):219-224.
• [20]JIANG Bo-ren,YANG Ying,JIN Hua,et al.Astragalo-side IV attenuates lipolysis and improves insulin resist-ance induced by TNFαin 3T3-L1 adipocytes.[J].Phytother Res,2008,22(11):1434-1439.
• [21]罗永姣,邓晖,李双杰,等.黄芪甲甙在Balb/C小鼠CVB3病毒性心肌炎中抗凋亡作用的机制[J].南华大学学报:医学版,2010,38(3):328-331.
• [22]刘丹莉,杨云华,于小华,等.黄芪甲甙干预小鼠骨髓间充质干细胞凋亡的研究[J].陕西医学杂志,2010:39(3):259-262.
• [23]王琳,闫晨.玉屏风散中黄芪甲苷的制备及抗炎作用的研究[J].天津药学,2007,19(1):31-32.
• [24]WANG S,LI J,HUANG H,et al.Anti-hepatitis B virusactivities of astragaloside IV isolated from radix Astra-gali[J].Biol Pharm Bull,2009,32(1):132-135.
• [25]QI Hong-yi,WEI Lai,HAN Yi-fan,et al.Proteomiccharacterization of the cellular response to chemopre-ventive triterpenoid astragaloside IV in human hepato-cellular carcinoma cell line HepG2.[J].Int J Oncol,2010,36(3):725-735.
• [26]陈然,张玉青,王颖,等.黄芪甲甙对大鼠离体肠系膜动脉血管舒缩功能的影响[J].温州医学院学报,2008,38(3):217-220.
• [27]ZHANG Chuan,WANG Xu-hui,ZHONG Mei-fang,etal.Mechanisms underlying vasorelaxant action of astra-galoside IV in isolated rat aortic rings[J].Clin ExpPharmacol Physiol,2007,34(5/6):387-392.
• [28]ZHANG Wei-dong,ZHANG Chuan,WANG Xu-hui,etal.Astragaloside IV dilates aortic vessels from normaland spontaneously hypertensive rats through endotheli-um-dependent and endothelium-independent ways[J].Planta Med,2006,72(7):621-626.
• [29]ZHU Jiang-bo,WAN Xu-ying,ZHU Yu-ping,et al.Effect of astragaloside IV on the embryo-fetal develop-ment of Sprague-dawley rats and new Zealand whiterabbits[J].J Appl Toxicol,2009,29(5):381-385.
• [30]WAN Xu-ying,ZHU Jiang-bo,ZHU Yu-ping,et al.Effect of astragaloside IVon the general and peripartumreproductive toxicity in Sprague-Dawley rats[J].Int JToxicol,2010,29(5):505-516.
• [31]梁从庆,周漩,宋粉云,等.薄层扫描法测定童康片中黄芪甲苷的含量[J].中国实验方剂学杂志,2004,10(5):9-10.
• [32]费继君,郝美玲,赵彬,等.双波长薄层扫描法测定康心宁颗粒中黄芪甲苷的含量[J].中华医药学杂志,2003,2(7):38-40.
• [33]田丰,邓英杰.HPLC法测定黄芪中的黄芪甲苷含量[J].沈阳药科大学学报,2000,17(1):43-45.
• [34]姚美村,毕开顺.柱前衍生化HPLC法测定黄芪中黄芪甲苷的含量[J].天然产物研究与开发,2000,12(4):17-22.
• [35]张金红,周晶,吴志丽,等.HPLC-ELSD法测定黄芪及金芪降糖片中黄芪甲苷的含量[J].天津医科大学学报,2010,16(1):26-29.
• [36]李翔,朱臻宇,朱东亮,等.高效液相色谱-蒸发光散射检测梯度洗脱法测定黄芪药材中黄芪甲苷的含量[J].第二军医大学学报,2006,27(3):331-333.
• [37]YAN Li-xin,GUO De-an.Quantitation of astragalosideIV in rat plasma by liquid chromatography-tandem massspectrometry[J].J Chromatogr B Analyt Technol Bi-omed Life Sci,2005,824(1/2):244-248.
• [38]ZHANG Wei-dong,ZHANG Chuan,LIU Run-hui,etal.Preclinical pharmacokinetics and tissue distributionof a natural cardioprotective agent astragaloside IV inrats and dogs[J].Life Sci,2006,79(8):808-815.
• [39]邢俊波,吴禾,刘云.正交设计优选黄芪中黄芪甲苷提取工艺[J].时珍国医国药,2005,16(9):819-820.
• [40]张宇,陈治松,王粟明.高效提取黄芪甲苷的工艺研究[J].黑龙江医药科学,2005,28(5):3-4.
• [41]李莉,谭蔚,马雪松.微波辅助提取黄芪甲苷的研究[J].中药材,2007,30(2):234-236.
• [42]孙海燕,关溯,黄民.黄芪甲苷的提取新工艺研究[J].中药材,2005,28(8):705-708.
• [43]张宇,吕哲,李鑫昶,等.黄芪总皂甙水解为黄芪甲苷的工艺研究[J].黑龙江医药科学,2001,24(4):136-137.
• [44]刘玫,周晶,张庆伟,等.氨液水解法用于提高黄芪中黄芪甲苷含量的工艺研究[J].中国中药杂志,2008,33(6):635-638.
• [45]杨晓雷,曹云.黄芪甲苷的提取工艺研究[J].精细化工原料及中间体,2008:18(12):30-32.
• [46]刘超,毛羽,肖丽丽,等.产黄芪甲苷酶的酶反应条件[J].大连工业大学学报,2008,27(2):113-116.
• [47]许平平,谭银春,鱼红闪,等.酶转化法提高黄芪甲苷的得率[J].大连工业大学学报,2009,28(1):20-22.